Lee Frank D. 4
4 · Bausch Health Companies Inc. · Filed May 26, 2026
Research Summary
AI-generated summary of this filing
Bausch Health (BHC) Director Frank D. Lee Receives RSU Award
What Happened
- Frank D. Lee, a director of Bausch Health Companies Inc. (BHC), was granted 45,871 restricted share units (RSUs) on 2026-05-22. The Form 4 reports an acquisition at $0.00 (standard for grants); the RSUs have a grant-date value of $250,000 and will be settled in common shares. The grant vests on the date immediately preceding the company’s next Annual Meeting of Shareholders.
Key Details
- Transaction date: 2026-05-22; Form 4 filed: 2026-05-26 (filed four days after the transaction).
- Amount: 45,871 RSUs; price reported: $0.00; grant-date value: $250,000 (per filing footnote).
- Vesting/settlement: RSUs vest immediately before the next annual meeting and will be settled in common shares.
- Footnote: RSUs are granted to non‑employee directors on the third business day following their election at the Annual Meeting (per F1).
- Shares owned after transaction: not specified in the filing.
- Filing timeliness: Form 4 was filed several days after the grant; Form 4s are typically due within two business days, so this may be a late filing.
Context
- This transaction is a standard director compensation award (code A = award/grant), not a market purchase or sale. RSU grants are common for non-employee directors and do not by themselves indicate buying or selling sentiment. There is no indication in the filing of tax-withholding sales or a 10b5-1 plan related to this grant.
Insider Transaction Report
Form 4
Lee Frank D.
Director
Transactions
- Award
Common Shares, No Par Value
[F1]2026-05-22+45,871→ 95,210 total
Footnotes (1)
- [F1]Represents the award of restricted share units ("RSUs") granted to non-employee directors of the Issuer on the third business day following their election at the Issuer's Annual Meeting of Shareholders. The RSUs have a grant date value of $250,000, vest on the date immediately preceding the Issuer's next Annual Meeting of Shareholders, and are settled in common shares, no par value, of the Issuer.
Signature
/s/ Brianna M. Dorsi, attorney-in-fact|2026-05-26